Bayer Considers Separating Agricultural Division as American Legal Disputes Continue to Depress Corporate Valuation
The managing board of the German pharmaceutical and chemical giant Bayer confirmed it is actively exploring the structural separation of its crop science division, seeking to isolate the billions of dollars in ongoing United States litigation costs related to the weedkiller Roundup.